Find Funding Opportunities

COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
NINDS Interest in Pain Research | View information, FAQs, resources, and available funding notices and opportunities.

All NINDS-related funding opportunity announcements (FOAs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed.Search the Closed Announcements tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-MH-22-315Release Date: Thursday, September 22, 2022Announcement Type: NOT
This notice alerts applicants about an upcoming Pre-Application and Technical Assistance Webinar for RFA-MH-22-240 on October 24, 2022.
Expiration Date: Saturday, June 7, 2025FOA Number: NOT-NS-23-027Release Date: Tuesday, September 20, 2022Announcement Type: NOT
The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-22-181 "NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional). AIDS Application due dates have been added for each council round.
Expiration Date: Thursday, May 8, 2025FOA Number: NOT-HD-22-043Release Date: Monday, September 19, 2022Announcement Type: Notice of Special Interest
The purpose of this Notice of Special Interest (NOSI) is to stimulate dissemination and implementation research on innovative approaches built on evidence-based findings from foundational research on factors that contribute to maternal morbidity and mortality (MMM). This NOSI will support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve preconception, pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-HL-22-044Release Date: Monday, September 19, 2022Announcement Type: NOT
The purpose of this Notice is to inform potential applicants that NHLBI has provided additional information regarding the allocation of our collaborating IC's funding contribution to the total proposed budget for RFA-HL-23-016: "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24)."
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-HL-22-047Release Date: Monday, September 19, 2022Announcement Type: NOT
The purpose of this Notice is to inform potential applicants that NHLBI has provided additional information regarding the allocation of our collaborating ICs' funding contribution to the total budget forRFA-HL-23-015"(New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3)".
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-EY-22-016Release Date: Thursday, September 15, 2022Announcement Type: NOT
This Notice informs potential applicants of the National Eye Institute's (NEI) participation in the funding opportunity announcement (FOA) PAR-22-181, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional).
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-024Release Date: Thursday, September 15, 2022Announcement Type: NOT
The purpose of this notice is to inform applicants of a change to the title to reflect NINR's participation in PAR-22-181 "NIDA, NIMH, NINR and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-025Release Date: Wednesday, September 14, 2022Announcement Type: NOT
The purpose of this notice is to inform applicants of a correction to section III. Eligibility Information for RFA-NS-22-038 "Research Program Award (R35 Clinical Trial Optional)".
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-023Release Date: Monday, September 12, 2022Announcement Type: NOT
The purpose of this notice is to inform applicants of a correction to section III. Eligibility Information for RFA-NS-22-038 "Research Program Award (R35 Clinical Trial Optional)".
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-22-115Release Date: Monday, September 12, 2022Announcement Type: NOT
This Notice announces an update to the NINDS Special Council Review (SCR) policy. The Notice: (1) aligns the NINDS policy with updated NIH Other Support disclosure requirements (see NOT-OD-21-169) and (2) increases the SCR threshold from $1.0 million in direct costs per year to $2.0 million in total costs (inclusive of direct and indirect costs), per year. This threshold does not represent a cap on NINDS funding and includes only active NIH awards.